In bleomycin-induced pulmonary fibrosis mice models, pharmacological Axl inhibition contributes to antifibrotic processes reducing factors associated with fibroblast differentiation and fibrosis [55]. The gene discussed is AXL; the disease is pulmonary fibrosis.